| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 01/04/1996 | WO1996000068A2 Combination therapy for hiv infection |
| 01/04/1996 | WO1996000060A1 Topical compositions comprising n-acetyl-l-cysteine |
| 01/04/1996 | WO1995033464A3 Retroviral protease inhibitor combinations |
| 01/04/1996 | WO1995031985A3 Pharmaceutical compositions comprising an opiate antagonist and calcium salts, their use for the treatment of endorphin-mediated pathologies |
| 01/04/1996 | CA2193860A1 T cell epitopes of rye grass pollen allergen |
| 01/04/1996 | CA2193725A1 Aryl derivative compounds and uses to inhibit phosphodiesterase iv acti vity |
| 01/04/1996 | CA2193654A1 Medical use of bromelain |
| 01/04/1996 | CA2193221A1 Combination therapy for hiv infection |
| 01/03/1996 | EP0690127A1 Compositions and methods for stimulating megakaryocyte growth and differentiation |
| 01/03/1996 | EP0690050A1 (Thia)cycloalkyl(b) indole derivatives as 5-lipoxygenase inhibitors |
| 01/03/1996 | EP0689588A1 Extracellular signal-regulated kinase, sequences, and methods of production and use |
| 01/03/1996 | EP0689549A1 New urea derivates, their preparation and their use |
| 01/03/1996 | EP0689538A1 Hydroxamic acid derivatives as metalloproteinase inhibitors |
| 01/03/1996 | EP0689536A1 Naphthalene derivatives |
| 01/03/1996 | EP0689450A1 Potassium channel blocking compounds and their use |
| 01/03/1996 | EP0689449A1 Therapeutical compositions for use in humans, characterised by a combination of a muramyl peptide and a cytokine |
| 01/03/1996 | EP0689443A1 The use of bisphosphonates in bone surgery |
| 01/03/1996 | EP0689431A1 New use of anti-acne agents |
| 01/03/1996 | EP0689428A1 Enhanced circulation effector composition and method |
| 01/03/1996 | EP0619806B1 Preparation of substituted piperidines |
| 01/03/1996 | EP0502169B1 Piperazine derivatives |
| 01/03/1996 | EP0473701B1 Recombinant dna method for production of parathyroid hormone |
| 01/03/1996 | EP0440686B1 Peptides representing epitopic sites on r-ifn-beta, antibodies thereto, and uses thereof |
| 01/03/1996 | CN1114312A Sulfonamidocarbonylpyridine-2-carboxamides and their pyridine-N-oxides, process for their preparation, and their use as pharmaceuticals |
| 01/03/1996 | CN1114310A 1H-indole-3-glyoxylamide spla2 inhibitors |
| 01/03/1996 | CN1030609C Methylenebisphosphonic acid derivatives |
| 01/03/1996 | CN1030608C Method of preparation for N-(pyrroloÛ2,3-dÙ pyrimidin-3-ylacyl)-glutamic acid derivatives |
| 01/02/1996 | US5481000 Process for preparing chiral [[(2-bromoethyl)-amino]methyl]-2-nitro-1H-imidazol-1-ethanol and related compounds |
| 01/02/1996 | US5480999 Containing an acid and an arginine analogue |
| 01/02/1996 | US5480983 Adenosine derivatives, preparation methods and pharmaceutical compositions containing them |
| 01/02/1996 | US5480906 Antitumor agents |
| 01/02/1996 | US5480903 Administering compounds or salts with carriers to skin for treating dermatitis including psoriasis |
| 01/02/1996 | US5480901 Method for reducing unwanted cellular adhesions |
| 01/02/1996 | US5480873 Arthritis |
| 01/02/1996 | US5480648 Transdermal prostaglandin composition |
| 01/02/1996 | US5480645 Hydroxyamines N-acyl derivatives having scavenger activity and useful in acute and chronic pathologies associated with peroxidation and inflammation phenomena |
| 01/02/1996 | US5480378 Apparatus for preparing a concentrate of coagulation factors from a blood sample |
| 01/02/1996 | CA2153083A1 Pharmaceutical compositions and a process for the preparation thereof |
| 01/02/1996 | CA2152981A1 Method of attenuating lung capillary leak in a mammal |
| 01/02/1996 | CA2032904C Blocking agents of edrf effect or formation for the treatment of shock |
| 12/30/1995 | CA2152233A1 Oligonucleotides to inhibit the expression of isoprenyl protein transferases |
| 12/29/1995 | CA2152725A1 (thia)cycloalkyl [b] indoles; process for preparing the same and pharmaceutical compositions containing them |
| 12/29/1995 | CA2152321A1 Compositions for treatment of diabetic complications |
| 12/28/1995 | WO1995035375A1 Interleukin-5 specific recombinant antibodies |
| 12/28/1995 | WO1995035372A1 5-lipoxygenase-activating protein ii |
| 12/28/1995 | WO1995035322A1 Esterified polyanionic cyclodextrins as smooth muscle cell proliferation inhibitors |
| 12/28/1995 | WO1995035310A1 Pyrrolidine derivatives for the treatment of cholecystokinine and gastrine-related disorders |
| 12/28/1995 | WO1995035308A1 INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME |
| 12/28/1995 | WO1995035302A1 Phosphinic acid derivatives with metallopeptidase inhibitory activity |
| 12/28/1995 | WO1995035300A1 N-substituted-(dihydroxyboryl)alkyl purine, indole and pyrimidine derivatives, useful as inhibitors of inflammatory cytokines |
| 12/28/1995 | WO1995035294A1 Protein kinase c inhibitors |
| 12/28/1995 | WO1995035293A1 Indol derivatives useful for the treatment of migraine, composition and utilization |
| 12/28/1995 | WO1995035286A1 New hiv protease inhibitors |
| 12/28/1995 | WO1995035284A1 Tri-substituted phenyl derivatives useful as pde iv inhibitors |
| 12/28/1995 | WO1995035283A1 Tri-substituted phenyl derivatives useful as pde iv inhibitors |
| 12/28/1995 | WO1995035281A1 Tri-substituted phenyl derivates useful as pde iv inhibitors |
| 12/28/1995 | WO1995035279A1 Substituted alkyldiamine derivatives and their use as tachykinin antagonists |
| 12/28/1995 | WO1995035276A1 Metalloproteinase inhibitors |
| 12/28/1995 | WO1995035275A1 Metalloproteinase inhibitors |
| 12/28/1995 | WO1995035107A1 Endothelin receptor antagonists |
| 12/28/1995 | WO1995035103A1 A pharmaceutical composition for the prevention and/or treatment of viral infections and optionally inflammations as well as a method for the treatment thereof |
| 12/28/1995 | WO1995035085A1 Stimulation of hair growth by peptide-copper complexes |
| 12/28/1995 | WO1995032203A3 Use of tetrahydropteridine derivatives as no-synthase inhibitors |
| 12/28/1995 | WO1995027495A3 Treatment of partial growth hormone insensitivity syndrome |
| 12/28/1995 | CA2193692A1 Metalloproteinase inhibitors |
| 12/28/1995 | CA2193691A1 Metalloproteinase inhibitors |
| 12/28/1995 | CA2193644A1 N-substituted-(dihydroxyboryl)alkyl purine, indole and pyrimidine derivatives, useful as inhibitors of inflammatory cytokines |
| 12/28/1995 | CA2193396A1 A pharmaceutical composition for the prevention and/or treatment of viral infections and optionally inflammations as well as a method for the treatment thereof |
| 12/28/1995 | CA2193220A1 New hiv protease inhibitors |
| 12/28/1995 | CA2193086A1 Esterified polyanionic cyclodextrins as smooth muscle cell proliferation inhibitors |
| 12/28/1995 | CA2169050A1 Indol derivatives useful for the treatment of migraine, composition and utilization |
| 12/27/1995 | EP0688869A1 Novel osteoinductive compositions |
| 12/27/1995 | EP0688787A1 Medicinal composition for bone resorption inhibition and osteogenesis acceleration |
| 12/27/1995 | EP0688360A1 Bone stimulating factor |
| 12/27/1995 | EP0688337A1 Compositions and methods for the treatment of immunomediated inflammatory disorders |
| 12/27/1995 | EP0688320A1 Tricyclic benzodiazepins, their use and preparation |
| 12/27/1995 | EP0688314A1 Prodrug derivatives of enzyme inhibitors with hydroxyl groups, methods of preparing them and their use |
| 12/27/1995 | EP0688219A1 Reduction of boar odor in meat |
| 12/27/1995 | EP0688215A1 3,4-diarylchromans for treatment of dermatitis |
| 12/27/1995 | EP0688213A1 Treatment of tumors with compounds having rxr retinoid receptor agonist activity |
| 12/27/1995 | EP0688211A1 Methods and compositions for inhibition of angiogenesis |
| 12/27/1995 | EP0688210A1 Use of carnosine or a combination with urocanic acid for treatment of photodermatoses |
| 12/27/1995 | EP0688209A1 Glycosylation of lipids and lipid-containing particles, and diagnostic and therapeutic methods and materials derived therefrom |
| 12/27/1995 | EP0607178A4 Methods for the selection, separation and fusion of cells. |
| 12/27/1995 | EP0584159B1 Nutrient preparation |
| 12/27/1995 | EP0471811B1 Allosteric hemoglobin modifiers |
| 12/27/1995 | EP0418230B1 Method for potentiating and inhibiting insulin-like growth factor activity |
| 12/27/1995 | EP0268663B1 Phosphopeptides |
| 12/27/1995 | CN1113754A Wrinkle eliminating cream and its preparation method |
| 12/26/1995 | US5478955 26,27-dimethylene-1α,25-dihydroxyvitamin D2 and 26, 27-dimethylene-24-epi-1α, 25-dihydroxyvitamin D2 and methods for preparing same |
| 12/26/1995 | US5478941 Enantiomers of 1-[(4-chlorophenyl)phenylmethyl]-4-[(4-methylphenyl) sulfonyl]piperazine |
| 12/26/1995 | US5478925 Peptides which block the binding of Tumor Necrosis Factor to its receptors |
| 12/26/1995 | US5478858 Respiratory system disorders, gastrointestinal disorders |
| 12/26/1995 | US5478857 Use of PLA2 inhibitors as treatment for alzheimer's disease |
| 12/26/1995 | US5478856 Styrene derivatives and salts thereof |
| 12/26/1995 | US5478852 Administering |
| 12/26/1995 | US5478847 Methods of use for inhibiting bone loss and lowering serum cholesterol |
| 12/26/1995 | US5478845 Piperidine derivatives |
| 12/26/1995 | US5478836 Treaing hypertension, atheroschlerosis |
| 12/26/1995 | US5478835 Tricyclic compounds and intermediates thereof |